CovidChloroV1, Main, Exploration, bibRecord, 000261

Pre-Exposure Prophylaxis for COVID-19 in Pregnant Women.

Identifieur interne : 000261 ( Main/Exploration ); précédent : 000260; suivant : 000262

Pre-Exposure Prophylaxis for COVID-19 in Pregnant Women.

Auteurs : Melissa C. Fesler [États-Unis] ; Raphael B. Stricker [États-Unis]

Source :

International journal of general medicine [ 1178-7074 ] ; 2021.

RBID : pubmed:33542646

Abstract

Pregnant women are at higher risk for developing severe complications of COVID-19 including preterm delivery, respiratory failure, and death. Although vaccines to prevent COVID-19 are being developed, pregnant women are not included in the current COVID-19 vaccine trials and initially this population may not be eligible for COVID-19 vaccines due to lack of safety testing in pregnancy. As an alternate approach, we discuss the concept of pre-exposure prophylaxis (PrEP) using medications that are approved for use in pregnant women to prevent gestational problems and severe illness in this high-risk population. In particular, the use of hydroxychloroquine PrEP affords a safe and readily available means to avoid COVID-19 complications in pregnancy.

DOI: 10.2147/IJGM.S295627
PubMed: 33542646
PubMed Central: PMC7851576

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000389
to stream Main, to step Curation: 000389

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pre-Exposure Prophylaxis for COVID-19 in Pregnant Women.</title>
<author><name sortKey="Fesler, Melissa C" sort="Fesler, Melissa C" uniqKey="Fesler M" first="Melissa C" last="Fesler">Melissa C. Fesler</name>
<affiliation wicri:level="2"><nlm:affiliation>Alan E. Beer Medical Center for Reproductive Immunology, Los Gatos, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Alan E. Beer Medical Center for Reproductive Immunology, Los Gatos, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:affiliation>Union Square Medical Associates, San Francisco, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Union Square Medical Associates, San Francisco, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Stricker, Raphael B" sort="Stricker, Raphael B" uniqKey="Stricker R" first="Raphael B" last="Stricker">Raphael B. Stricker</name>
<affiliation wicri:level="2"><nlm:affiliation>Alan E. Beer Medical Center for Reproductive Immunology, Los Gatos, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Alan E. Beer Medical Center for Reproductive Immunology, Los Gatos, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:affiliation>Union Square Medical Associates, San Francisco, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Union Square Medical Associates, San Francisco, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:33542646</idno>
<idno type="pmid">33542646</idno>
<idno type="doi">10.2147/IJGM.S295627</idno>
<idno type="pmc">PMC7851576</idno>
<idno type="wicri:Area/Main/Corpus">000389</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000389</idno>
<idno type="wicri:Area/Main/Curation">000389</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000389</idno>
<idno type="wicri:Area/Main/Exploration">000389</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Pre-Exposure Prophylaxis for COVID-19 in Pregnant Women.</title>
<author><name sortKey="Fesler, Melissa C" sort="Fesler, Melissa C" uniqKey="Fesler M" first="Melissa C" last="Fesler">Melissa C. Fesler</name>
<affiliation wicri:level="2"><nlm:affiliation>Alan E. Beer Medical Center for Reproductive Immunology, Los Gatos, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Alan E. Beer Medical Center for Reproductive Immunology, Los Gatos, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:affiliation>Union Square Medical Associates, San Francisco, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Union Square Medical Associates, San Francisco, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Stricker, Raphael B" sort="Stricker, Raphael B" uniqKey="Stricker R" first="Raphael B" last="Stricker">Raphael B. Stricker</name>
<affiliation wicri:level="2"><nlm:affiliation>Alan E. Beer Medical Center for Reproductive Immunology, Los Gatos, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Alan E. Beer Medical Center for Reproductive Immunology, Los Gatos, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:affiliation>Union Square Medical Associates, San Francisco, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Union Square Medical Associates, San Francisco, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">International journal of general medicine</title>
<idno type="ISSN">1178-7074</idno>
<imprint><date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Pregnant women are at higher risk for developing severe complications of COVID-19 including preterm delivery, respiratory failure, and death. Although vaccines to prevent COVID-19 are being developed, pregnant women are not included in the current COVID-19 vaccine trials and initially this population may not be eligible for COVID-19 vaccines due to lack of safety testing in pregnancy. As an alternate approach, we discuss the concept of pre-exposure prophylaxis (PrEP) using medications that are approved for use in pregnant women to prevent gestational problems and severe illness in this high-risk population. In particular, the use of hydroxychloroquine PrEP affords a safe and readily available means to avoid COVID-19 complications in pregnancy.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33542646</PMID>
<DateRevised><Year>2021</Year>
<Month>02</Month>
<Day>06</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-7074</ISSN>
<JournalIssue CitedMedium="Print"><Volume>14</Volume>
<PubDate><Year>2021</Year>
</PubDate>
</JournalIssue>
<Title>International journal of general medicine</Title>
<ISOAbbreviation>Int J Gen Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Pre-Exposure Prophylaxis for COVID-19 in Pregnant Women.</ArticleTitle>
<Pagination><MedlinePgn>279-284</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.2147/IJGM.S295627</ELocationID>
<Abstract><AbstractText>Pregnant women are at higher risk for developing severe complications of COVID-19 including preterm delivery, respiratory failure, and death. Although vaccines to prevent COVID-19 are being developed, pregnant women are not included in the current COVID-19 vaccine trials and initially this population may not be eligible for COVID-19 vaccines due to lack of safety testing in pregnancy. As an alternate approach, we discuss the concept of pre-exposure prophylaxis (PrEP) using medications that are approved for use in pregnant women to prevent gestational problems and severe illness in this high-risk population. In particular, the use of hydroxychloroquine PrEP affords a safe and readily available means to avoid COVID-19 complications in pregnancy.</AbstractText>
<CopyrightInformation>© 2021 Fesler and Stricker.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fesler</LastName>
<ForeName>Melissa C</ForeName>
<Initials>MC</Initials>
<AffiliationInfo><Affiliation>Alan E. Beer Medical Center for Reproductive Immunology, Los Gatos, CA, USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Union Square Medical Associates, San Francisco, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Stricker</LastName>
<ForeName>Raphael B</ForeName>
<Initials>RB</Initials>
<Identifier Source="ORCID">0000-0003-2149-8517</Identifier>
<AffiliationInfo><Affiliation>Alan E. Beer Medical Center for Reproductive Immunology, Los Gatos, CA, USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Union Square Medical Associates, San Francisco, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2021</Year>
<Month>01</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>New Zealand</Country>
<MedlineTA>Int J Gen Med</MedlineTA>
<NlmUniqueID>101515487</NlmUniqueID>
<ISSNLinking>1178-7074</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="N">hydroxychloroquine</Keyword>
<Keyword MajorTopicYN="N">pre-exposure prophylaxis</Keyword>
<Keyword MajorTopicYN="N">pregnancy</Keyword>
<Keyword MajorTopicYN="N">vaccine</Keyword>
</KeywordList>
<CoiStatement>RBS is the owner of the Alan E. Beer Medical Center for Reproductive Immunology and reports no other potential conflicts of interest for this work. MCF has no conflicts of interest for this work to declare.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>12</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2021</Year>
<Month>01</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2021</Year>
<Month>2</Month>
<Day>5</Day>
<Hour>5</Hour>
<Minute>58</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2021</Year>
<Month>2</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2021</Year>
<Month>2</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33542646</ArticleId>
<ArticleId IdType="doi">10.2147/IJGM.S295627</ArticleId>
<ArticleId IdType="pii">295627</ArticleId>
<ArticleId IdType="pmc">PMC7851576</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Lancet. 2020 May 23;395(10237):e92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32410758</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Clin Pharmacol. 2016 May;81(5):835-48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26700396</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Jul 10;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32648892</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4539-4547</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32373993</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Sep 5;396(10252):e22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32861313</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Rheum Dis. 1996 Jul;55(7):486-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8774170</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Can Fam Physician. 2011 Nov;57(11):1279-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22084457</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Obstet Gynecol Scand. 2020 Jul;99(7):819-822</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32386441</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Morb Mortal Wkly Rep. 2020 Nov 06;69(44):1641-1647</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33151921</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dev Ctries. 2020 Sep 30;14(9):982-986</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33031085</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Future Microbiol. 2018 Feb;13:137-139</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29302996</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Infect Dis. 2019 Oct;32(5):407-412</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31305490</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Comput Methods Appl Mech Eng. 2019 May 1;348:313-333</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32863454</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Obstet Gynaecol Can. 2016 Oct;38(10):945-954</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27720094</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arthritis Rheum. 2003 Nov;48(11):3207-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14613284</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Obstet Gynecol. 2020 Aug;136(2):273-282</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32555034</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Occup Environ Med. 2020 Dec 9;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33298533</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Reprod Toxicol. 2013 Aug;39:58-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23602891</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Emerg Med. 2020 Dec 11;40:41-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33348222</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arthritis Rheum. 2006 Nov;54(11):3640-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17075810</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Pharmacokinet. 2019 Apr;58(4):525-533</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30255310</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Glob Health. 2020 Jan;8(1):e12-e13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31839127</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Indian J Med Res. 2020 May;151(5):459-467</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32611916</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2021 Feb;27(2):638-641</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33185524</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol Res. 2017;2017:2810202</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29392142</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Obstet Gynecol. 2020 Dec;136(6):1117-1125</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33027186</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Rev Allergy Immunol. 2012 Apr;42(2):145-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21221847</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Open Forum Infect Dis. 2020 Oct 19;7(11):ofaa500</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33204764</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2021 Jan;57(1):106222</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33189891</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Morb Mortal Wkly Rep. 2020 Nov 06;69(44):1635-1640</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33151917</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Assoc Physicians India. 2020 Nov;68(11):14-19</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33187030</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Travel Med. 2019 Jun 1;26(4):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30544231</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 Feb 19;368:m331</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32075790</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Clin Pathol. 2020 Jun 8;154(1):23-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32441303</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cochrane Database Syst Rev. 2018 Nov 14;11:CD011444</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30480761</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Rheumatol. 2011 Dec;38(12):2504-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22002012</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biochem Biophys Res Commun. 2005 Jun 17;331(4):1193-200</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15883002</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Glob Health. 2020 Dec 16;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33340453</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Obstet Gynecol. 2020 Nov 20;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33221292</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arthritis Rheumatol. 2020 Apr;72(4):529-556</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32090480</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lupus. 2018 May;27(6):1012-1017</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29301469</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lupus. 2019 Apr;28(4):555-559</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30755141</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Paediatr. 2010 Jan;99(1):4; author reply 4-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19895609</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arthritis Rheum. 2004 Sep;50(9):3056-7; author reply 3057-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15457485</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Inflammopharmacology. 2018 Oct;26(5):1141-1149</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29948492</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Drug Resist. 2020 Oct 19;13:3689-3694</Citation>
<ArticleIdList><ArticleId IdType="pubmed">33116688</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Perinatol. 2005 Feb;25(2):86-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15496869</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Californie</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Californie"><name sortKey="Fesler, Melissa C" sort="Fesler, Melissa C" uniqKey="Fesler M" first="Melissa C" last="Fesler">Melissa C. Fesler</name>
</region>
<name sortKey="Fesler, Melissa C" sort="Fesler, Melissa C" uniqKey="Fesler M" first="Melissa C" last="Fesler">Melissa C. Fesler</name>
<name sortKey="Stricker, Raphael B" sort="Stricker, Raphael B" uniqKey="Stricker R" first="Raphael B" last="Stricker">Raphael B. Stricker</name>
<name sortKey="Stricker, Raphael B" sort="Stricker, Raphael B" uniqKey="Stricker R" first="Raphael B" last="Stricker">Raphael B. Stricker</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000261 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000261 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:33542646
   |texte=   Pre-Exposure Prophylaxis for COVID-19 in Pregnant Women.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:33542646" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Pre-Exposure Prophylaxis for COVID-19 in Pregnant Women.

Pre-Exposure Prophylaxis for COVID-19 in Pregnant Women.

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki